InMed Pharmaceuticals Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2023 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2023 to Q3 2024.
- InMed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $84.1K, a 1666% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)